ATE304861T1 - Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia - Google Patents

Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia

Info

Publication number
ATE304861T1
ATE304861T1 AT02787156T AT02787156T ATE304861T1 AT E304861 T1 ATE304861 T1 AT E304861T1 AT 02787156 T AT02787156 T AT 02787156T AT 02787156 T AT02787156 T AT 02787156T AT E304861 T1 ATE304861 T1 AT E304861T1
Authority
AT
Austria
Prior art keywords
sarcopenia
ginkgo biloba
medication
extracts
producing
Prior art date
Application number
AT02787156T
Other languages
English (en)
Inventor
Yves Christen
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE304861T1 publication Critical patent/ATE304861T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02787156T 2001-07-17 2002-07-16 Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia ATE304861T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109506A FR2827518B1 (fr) 2001-07-17 2001-07-17 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
PCT/FR2002/002519 WO2003007973A1 (fr) 2001-07-17 2002-07-16 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie

Publications (1)

Publication Number Publication Date
ATE304861T1 true ATE304861T1 (de) 2005-10-15

Family

ID=8865590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02787156T ATE304861T1 (de) 2001-07-17 2002-07-16 Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia

Country Status (17)

Country Link
US (2) US7138148B2 (de)
EP (1) EP1411961B1 (de)
JP (1) JP4510445B2 (de)
KR (1) KR100891393B1 (de)
CN (1) CN1272016C (de)
AT (1) ATE304861T1 (de)
AU (1) AU2002334001B2 (de)
CA (1) CA2453254C (de)
DE (1) DE60206280T2 (de)
DK (1) DK1411961T3 (de)
ES (1) ES2250726T3 (de)
FR (1) FR2827518B1 (de)
HU (1) HUP0400928A3 (de)
NZ (1) NZ530367A (de)
PL (1) PL202567B1 (de)
RU (1) RU2298411C2 (de)
WO (1) WO2003007973A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842425B1 (fr) * 2002-07-16 2005-04-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
US8058211B2 (en) * 2007-12-12 2011-11-15 Halliburton Energy Services, Inc. Corrosion inhibitor intensifier compositions and associated methods
US20120296403A1 (en) 2010-02-10 2012-11-22 Novartis Ag Methods and compounds for muscle growth
US9029558B2 (en) 2011-08-18 2015-05-12 Semiconductor Energy Laboratory Co., Ltd. Carbazole compound, light-emitting element, light-emitting device, electronic device, and lighting device
KR102051433B1 (ko) 2013-08-27 2020-01-08 (주)네오팜 근육 분화 촉진 및 근육 강화용 조성물 및 외용제
KR101771486B1 (ko) 2015-06-25 2017-08-25 서울대학교산학협력단 특정 다마란 계열의 성분이 증가된 인삼추출물의 제조방법 및 이를 이용한 근육감소증 관련 질환 치료용 조성물
KR102281263B1 (ko) 2019-03-12 2021-07-26 주식회사 비티씨 갈릭산, 에피카테킨(ec), 및 에피갈로카테킨(egc)의 함량이 증가된 카테킨 효소처리물 및 이의 제조방법
US20200375937A1 (en) 2019-05-31 2020-12-03 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
KR102229177B1 (ko) 2019-12-27 2021-03-18 부산대학교 산학협력단 로즈마리 추출물 및 대두 추출물을 유효성분으로 함유하는 근육 감소증 예방 또는 치료용 조성물
KR20240133112A (ko) 2023-02-28 2024-09-04 주식회사 건강중심주의 근육 감소 관련 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
WO1998000024A1 (en) * 1996-06-28 1998-01-08 Viva America Marketing, Inc. Nutritional supplement composition and use
FR2763592B1 (fr) * 1997-05-20 1999-07-16 Sod Conseils Rech Applic Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
JP3293524B2 (ja) * 1997-06-17 2002-06-17 有限会社薬研 イチョウ葉抽出エキス担持粉体複合物及びその製造方法
FR2771639B1 (fr) * 1997-12-03 2000-05-05 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
JP4142253B2 (ja) * 1998-05-11 2008-09-03 ノボ ノルディスク アクティーゼルスカブ 成長ホルモン放出特性を有する化合物
RU2141320C1 (ru) * 1998-07-14 1999-11-20 Научно-исследовательский институт фармакологии Томского научного центра РАМН Гемореологическое средство
FR2782008B1 (fr) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
DK1411961T3 (da) 2006-02-06
HUP0400928A3 (en) 2008-04-28
EP1411961B1 (de) 2005-09-21
WO2003007973A1 (fr) 2003-01-30
US20040166180A1 (en) 2004-08-26
DE60206280T2 (de) 2006-07-27
NZ530367A (en) 2006-05-26
CA2453254A1 (fr) 2003-01-30
KR100891393B1 (ko) 2009-04-02
CN1533281A (zh) 2004-09-29
FR2827518B1 (fr) 2005-07-08
ES2250726T3 (es) 2006-04-16
US7232580B2 (en) 2007-06-19
RU2298411C2 (ru) 2007-05-10
EP1411961A1 (de) 2004-04-28
PL202567B1 (pl) 2009-07-31
JP2005512956A (ja) 2005-05-12
RU2004104463A (ru) 2005-06-10
AU2002334001B2 (en) 2007-07-19
PL367089A1 (en) 2005-02-21
DE60206280D1 (de) 2006-02-02
HUP0400928A1 (hu) 2004-07-28
KR20040013150A (ko) 2004-02-11
FR2827518A1 (fr) 2003-01-24
JP4510445B2 (ja) 2010-07-21
CN1272016C (zh) 2006-08-30
CA2453254C (fr) 2011-02-15
US20060121135A1 (en) 2006-06-08
US7138148B2 (en) 2006-11-21
HK1069327A1 (en) 2005-05-20

Similar Documents

Publication Publication Date Title
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
ATE281162T1 (de) Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose
ATE304861T1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
DE69809284D1 (de) Immunomodulator mit anti-mikrobakteriellen und anti-mykobakteriellen eigenschaften, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen zur behandlung von mykobakteriosen sowie von chronischen und nicht-spezifischen lungenzuständen, sexuell übertragbaren krankheiten und den daraus resultierenden immunschwächen
DE60312505D1 (de) Injektion aus ixeris sonchifolia zur behandlung von kardiozerebralen gefässerkrankungen und funduserkrankungen sowie herstellungsverfahren dafür
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE448788T1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
ATE410172T1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE294582T1 (de) Verwendung von alpha-1-adrenorezeptor- antagonisten zur herstellung eines medikaments für die vorbeugung und die behandlung von krebs
DE60335892D1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung und/oder fettleibigkeit im zusammenhang steht
UA67795C2 (uk) Склад для лікування опікових ран, який включає мірамістин
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
ATE382347T1 (de) Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
ATE466587T1 (de) Valeriana officinalis extrakt zur behandlung von schlafapnoe oder hypopnoe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411961

Country of ref document: EP

EEIH Change in the person of patent owner